Loading clinical trials...
Loading clinical trials...
Risk-adapted Therapy for Primary Acute Myeloid Leukemia (AML) in Adult Patients up to 70 Years Old
Conditions
Interventions
Idarubicin
Ara-C
+4 more
Locations
15
Spain
ICO Badalona-Hospital Universitari Germans Trias i Pujol
Badalona, Barcelona, Spain
ICO Hospital Universitari de Bellvitge
L'Hospitalet de Llobregat, Barcelona, Spain
Hospital Universitari Son Espases
Palma de Mallorca, Mallorca, Spain
Hospital Universitari Son Llatzer
Palma de Mallorca, Mallorca, Spain
Hospital Verge de la Cinta
Tortosa, Tarragona, Spain
Hospital del Mar
Barcelona, Spain
Start Date
February 1, 2012
Primary Completion Date
July 31, 2022
Completion Date
November 10, 2022
Last Updated
June 27, 2023
NCT06852222
NCT06580106
NCT06501196
NCT06384261
NCT06382168
NCT06326268
Lead Sponsor
Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions